These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
117 related items for PubMed ID: 1544839
1. Bis-bioreductive agents as hypoxia-selective cytotoxins: nitracrine N-oxide. Wilson WR, Van Zijl P, Denny WA. Int J Radiat Oncol Biol Phys; 1992; 22(4):693-6. PubMed ID: 1544839 [Abstract] [Full Text] [Related]
2. Hypoxia-selective antitumor agents. 13. Effects of acridine substitution on the hypoxia-selective cytotoxicity and metabolic reduction of the bis-bioreductive agent nitracrine N-oxide. Lee HH, Wilson WR, Ferry DM, van Zijl P, Pullen SM, Denny WA. J Med Chem; 1996 Jun 21; 39(13):2508-17. PubMed ID: 8691448 [Abstract] [Full Text] [Related]
3. Comparison of aromatic and tertiary amine N-oxides of acridine DNA intercalators as bioreductive drugs. Cytotoxicity, DNA binding, cellular uptake, and metabolism. Siim BG, Hicks KO, Pullen SM, van Zijl PL, Denny WA, Wilson WR. Biochem Pharmacol; 2000 Oct 01; 60(7):969-78. PubMed ID: 10974206 [Abstract] [Full Text] [Related]
4. Nitracrine N-oxides: effects of variations in the nature of the side chain N-oxide on hypoxia-selective cytotoxicity. Lee HH, Wilson WR, Denny WA. Anticancer Drug Des; 1999 Dec 01; 14(6):487-97. PubMed ID: 10834270 [Abstract] [Full Text] [Related]
5. Tertiary amine N-oxides as bioreductive drugs: DACA N-oxide, nitracrine N-oxide and AQ4N. Wilson WR, Denny WA, Pullen SM, Thompson KM, Li AE, Patterson LH, Lee HH. Br J Cancer Suppl; 1996 Jul 01; 27():S43-7. PubMed ID: 8763844 [Abstract] [Full Text] [Related]
6. 5-Nitro-4-(N,N-dimethylaminopropylamino)quinoline (5-nitraquine), a new DNA-affinic hypoxic cell radiosensitizer and bioreductive agent: comparison with nitracrine. Wilson WR, Siim BG, Denny WA, van Zijl PL, Taylor ML, Chambers DM, Roberts PB. Radiat Res; 1992 Sep 01; 131(3):257-65. PubMed ID: 1438685 [Abstract] [Full Text] [Related]
7. Hypoxia-selective radiosensitization of mammalian cells by nitracrine, an electron-affinic DNA intercalator. Roberts PB, Anderson RF, Wilson WR. Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Apr 01; 51(4):641-54. PubMed ID: 3495509 [Abstract] [Full Text] [Related]
8. Reductive metabolism and hypoxia-selective toxicity of nitracrine. Wilson WR, Denny WA, Stewart GM, Fenn A, Probert JC. Int J Radiat Oncol Biol Phys; 1986 Jul 01; 12(7):1235-8. PubMed ID: 3744944 [Abstract] [Full Text] [Related]
9. Hypoxia-selective antitumor agents. 4. Relationships between structure, physicochemical properties, and hypoxia-selective cytotoxicity for nitracrine analogues with varying side chains: the "iminoacridan hypothesis". Denny WA, Atwell GJ, Anderson RF, Wilson WR. J Med Chem; 1990 May 01; 33(5):1288-95. PubMed ID: 2329552 [Abstract] [Full Text] [Related]
10. Selective toxicity of nitracrine to hypoxic mammalian cells. Wilson WR, Denny WA, Twigden SJ, Baguley BC, Probert JC. Br J Cancer; 1984 Feb 01; 49(2):215-23. PubMed ID: 6696822 [Abstract] [Full Text] [Related]
11. Hypoxia-selective antitumor agents. 12. Nitrobenzyl quaternary salts as bioreductive prodrugs of the alkylating agent mechlorethamine. Tercel M, Wilson WR, Anderson RF, Denny WA. J Med Chem; 1996 Mar 01; 39(5):1084-94. PubMed ID: 8676343 [Abstract] [Full Text] [Related]
12. Metabolic and radiolytic reduction of 4-alkylamino-5-nitroquinoline bioreductive drugs. Relationship to hypoxia-selective cytotoxicity. Siim BG, Atwell GJ, Wilson WR. Biochem Pharmacol; 1994 Oct 18; 48(8):1593-604. PubMed ID: 7980625 [Abstract] [Full Text] [Related]
13. Hypoxia-selective antitumor agents. 2. Electronic effects of 4-substituents on the mechanisms of cytotoxicity and metabolic stability of nitracrine derivatives. Wilson WR, Thompson LH, Anderson RF, Denny WA. J Med Chem; 1989 Jan 18; 32(1):31-8. PubMed ID: 2909741 [Abstract] [Full Text] [Related]
14. The reaction between nitracrine and glutathione: implications for hypoxic cell radiosensitization and cytotoxicity. Wilson WR, Anderson RF. Int J Radiat Oncol Biol Phys; 1989 Apr 18; 16(4):1001-5. PubMed ID: 2703377 [Abstract] [Full Text] [Related]
15. Hypoxia-selective antitumor agents. 8. Bis(nitroimidazolyl)alkanecarboxamides: a new class of hypoxia-selective cytotoxins and hypoxic cell radiosensitisers. Hay MP, Wilson WR, Moselen JW, Palmer BD, Denny WA. J Med Chem; 1994 Feb 04; 37(3):381-91. PubMed ID: 8308864 [Abstract] [Full Text] [Related]
16. Cytotoxic palladium complexes of bioreductive quinoxaline N1,N4-dioxide prodrugs. Urquiola C, Vieites M, Torre MH, Cabrera M, Lavaggi ML, Cerecetto H, González M, Cerain AL, Monge A, Smircich P, Garat B, Gambino D. Bioorg Med Chem; 2009 Feb 15; 17(4):1623-9. PubMed ID: 19162490 [Abstract] [Full Text] [Related]
17. Hypoxia-selective antitumor agents. 14. Synthesis and hypoxic cell cytotoxicity of regioisomers of the hypoxia-selective cytotoxin 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide. Palmer BD, Wilson WR, Anderson RF, Boyd M, Denny WA. J Med Chem; 1996 Jun 21; 39(13):2518-28. PubMed ID: 8691449 [Abstract] [Full Text] [Related]
18. Oxygen dependence of the cytotoxicity and metabolic activation of 4-alkylamino-5-nitroquinoline bioreductive drugs. Siim BG, Atwell GJ, Wilson WR. Br J Cancer; 1994 Oct 21; 70(4):596-603. PubMed ID: 7917903 [Abstract] [Full Text] [Related]
19. Hypoxia-selective antitumor agents. 1. Relationships between structure, redox properties and hypoxia-selective cytotoxicity for 4-substituted derivatives of nitracrine. Wilson WR, Anderson RF, Denny WA. J Med Chem; 1989 Jan 21; 32(1):23-30. PubMed ID: 2909736 [Abstract] [Full Text] [Related]
20. Hypoxia-selective antitumor agents. 7. Metal complexes of aliphatic mustards as a new class of hypoxia-selective cytotoxins. Synthesis and evaluation of cobalt(III) complexes of bidentate mustards. Ware DC, Palmer BD, Wilson WR, Denny WA. J Med Chem; 1993 Jun 25; 36(13):1839-46. PubMed ID: 8515422 [Abstract] [Full Text] [Related] Page: [Next] [New Search]